2018
DOI: 10.1016/j.micpath.2018.01.043
|View full text |Cite
|
Sign up to set email alerts
|

The multi-faceted potential of plant-derived metabolites as antimicrobial agents against multidrug-resistant pathogens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
61
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 87 publications
(61 citation statements)
references
References 74 publications
0
61
0
Order By: Relevance
“…The emergence of antibiotic resistant bacteria due to overuse, the innate antibiotic resistance of Aeromonas species, plus limiting factors of synthetic chemicals due to their potential carcinogenic effects, acute toxicity and environmental hazards has encouraged research into promising substitutes in order to control multidrug resistant microorganisms (Mulyaningsih, Sporer, Zimmermann, Reichling, & Wink, ). Botanical derivatives, in particular plant essential oils (EOs), have shown promise as alternative therapeutic agents (da Cunha, Heinzmann, & Baldisserotto, ; Shin, Prabhakaran, & Kim, ).…”
Section: Introductionmentioning
confidence: 99%
“…The emergence of antibiotic resistant bacteria due to overuse, the innate antibiotic resistance of Aeromonas species, plus limiting factors of synthetic chemicals due to their potential carcinogenic effects, acute toxicity and environmental hazards has encouraged research into promising substitutes in order to control multidrug resistant microorganisms (Mulyaningsih, Sporer, Zimmermann, Reichling, & Wink, ). Botanical derivatives, in particular plant essential oils (EOs), have shown promise as alternative therapeutic agents (da Cunha, Heinzmann, & Baldisserotto, ; Shin, Prabhakaran, & Kim, ).…”
Section: Introductionmentioning
confidence: 99%
“…The synergistic effect is observed when the antimicrobial activity of a combination of compounds is higher than the sum of the effects of individual compounds. Finally, the antagonism means that the activity of a combination of compounds is lower than the activities of individual compounds [22,27,160,161]. In Table S2, some examples of synergistic combinations of SMoPs and antibiotics are given, illustrating the significant reduction of bactericidal concentrations in comparison with antibiotics that are given without SMoPs.…”
Section: Safety In Numbers: Synergism In "Metabolite-metabolite" or "mentioning
confidence: 99%
“…This topic is extremely relevant today with the emergence and spread of completely drug-resistant strains of microorganisms. Many questions remain despite the fact that the antibacterial properties of secondary plant metabolites have been studied for a long time [15,[18][19][20][21][22][23][24][25][26][27][28]. First, in the huge sea of substances that are produced by plants, some are already known about, but still insufficiently studied and some are not yet discovered.…”
Section: Introductionmentioning
confidence: 99%
“…The first efflux pump inhibitor against RND‐type efflux pumps, reported by Lomovskaya et al , 15 was a phenylalanine–arginine β‐naphthylamide (PAβN) effective against Mex pumps in Pseudomonas aeruginosa and AcrB pumps in E. coli . Since then, various synthetic and natural compounds have been screened for their ability to inhibit efflux pumps 16–20 …”
Section: Introductionmentioning
confidence: 99%
“…Since then, various synthetic and natural compounds have been screened for their ability to inhibit efflux pumps. [16][17][18][19][20] However, little is known about efflux inhibitors for the ABC-type pump MacAB. Here, we describe a screening of inhibitors of MacAB in Salmonella and the identification of a compound that increases the susceptibility of a MacABexpressing Salmonella strain to macrolides.…”
Section: Introductionmentioning
confidence: 99%